Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aegerion Pharmaceuticals, Inc. (AEGR) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aegerion Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1338042.
Total stock buying since 2014: $3,522,773.
Total stock sales since 2014: $0.
Total stock option exercises since 2014: $9,856.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2016 | 351,000 | $589,598 | 0 | $0 | 6,954 | $0 |
| 2015 | 40,100 | $440,097 | 0 | $0 | 0 | $0 |
| 2014 | 75,150 | $2,493,078 | 0 | $0 | 6,400 | $9,856 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2016-09 | 351,000 | $589,598 | 0 | $0 | 1,642 | $0 |
| 2016-07 | 0 | $0 | 0 | $0 | 2,222 | $0 |
| 2016-04 | 0 | $0 | 0 | $0 | 867 | $0 |
| 2016-01 | 0 | $0 | 0 | $0 | 2,223 | $0 |
| 2015-11 | 40,100 | $440,097 | 0 | $0 | 0 | $0 |
| 2014-08 | 1,150 | $35,236 | 0 | $0 | 0 | $0 |
| 2014-07 | 10,000 | $339,050 | 0 | $0 | 0 | $0 |
| 2014-06 | 10,000 | $301,200 | 0 | $0 | 0 | $0 |
| 2014-05 | 54,000 | $1,817,592 | 0 | $0 | 6,400 | $9,856 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-09-17 | Harshbarger Benjamin (General Counsel) | Option Ex | 1,642 | .00 | 0 |
| 2016-09-13 | Broadfin Capital, Llc | Buy | 75,000 | 1.75 | 131,250 |
| 2016-09-12 | Kotler Kevin | Buy | 176,000 | 1.70 | 298,848 |
| 2016-09-09 | Kotler Kevin | Buy | 100,000 | 1.59 | 159,500 |
| 2016-07-27 | Smith Sandford D (Director) | Option Ex | 2,222 | .00 | 0 |
| 2016-04-01 | Harshbarger Benjamin (General Counsel) | Option Ex | 867 | .00 | 0 |
| 2016-01-27 | Smith Sandford D (Director) | Option Ex | 2,223 | .00 | 0 |
| 2015-11-11 | Kotler Kevin | Buy | 40,100 | 10.97 | 440,097 |
| 2014-08-19 | Fitzpatrick Mark J. (Chief Financial Officer) | Buy | 1,150 | 30.64 | 35,236 |
| 2014-07-31 | Beer Marc D (Chief Executive Officer) | Buy | 10,000 | 33.91 | 339,050 |
| 2014-06-03 | Beer Marc D (Chief Executive Officer) | Buy | 10,000 | 30.12 | 301,200 |
| 2014-05-27 | Beer Marc D (Chief Executive Officer) | Buy | 10,000 | 31.59 | 315,900 |
| 2014-05-21 | Beer Marc D (Chief Executive Officer) | Option Ex | 6,400 | 1.54 | 9,856 |
| 2014-05-20 | Beer Marc D (Chief Executive Officer) | Buy | 10,000 | 30.53 | 305,300 |
| 2014-05-08 | Beer Marc D (Chief Executive Officer) | Buy | 30,000 | 35.31 | 1,059,300 |
| 2014-05-08 | Vanlent Anne (Director) | Buy | 4,000 | 34.27 | 137,092 |
Insider trading activities including stock purchases, stock sales, and option exercises of AEGR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aegerion Pharmaceuticals, Inc. (symbol AEGR, CIK number 1338042) see the Securities and Exchange Commission (SEC) website.